Reducing low-density lipoprotein cholesterol (LDL-C) levels is a key target for lowering
cardiovascular risk and preventing atherosclerotic cardiovascular disease (ASCVD). Red …

Poor adherence to statin therapy is linked to significantly increased risk of cardiovascular
events and death. Unfortunately, adherence to statins is far from optimal. This is an alarming …

Purpose Systemic exposure to rosuvastatin is approximately double that of Caucasians in
Asian subjects. We investigated whether this pattern of increased exposure exists for other …

Statin treatment to reduce low-density lipoprotein cholesterol (LDL-C) is associated with the
prevention of cardiovascular events in Western patients. Similar results have been reported …

Results CURVES study compared the effect on lipid profile between atorvastatin and other
statins. This study demonstrated that low-density lipoprotein cholesterol (LDL-C), total …

目的观察短期应用阿托伐他汀对冠心病性心力衰竭患者血浆超敏C 反应蛋白(hs-CRP), N
末端脑利钠肽前体(NT-proBNP) 水平及心功能的影响. 方法选择冠心病性心力衰竭患者52 例 …

Background To investigate the associations between atorvastatin-induced liver injury (AILI)
and polymorphisms in eight genes possibly involved in the hepatic metabolism (CYP2C9 …

Sažetak Concomitant treatment with drugs that inhibit drug metabolising enzymes and/or
transporters, such as commonly prescribed statins and nonsteroidal anti-inflammatory drugs …

Background: Statins have proven cardioprotective effects, but higher doses are
accompanied by various concerns and may not lead to superior clinical outcomes in …

Background Statins are effective agents in the primary and secondary prevention of
cardiovascular disease, but treatment response to statins varies among individuals. We …